POZEN Inc. POZN, a pharmaceutical company
committed to developing medicine that transforms lives, today announced
that it has formed POZEN Limited, a wholly owned Irish subsidiary and
has entered in an Intangible Property Transfer Arrangement between POZEN
Inc. and POZEN Limited.
The company has been evaluating its strategic options since recovering
the U.S. commercial rights on YOSPRALA in November 2014 and recently
announced hiring Adrian Adams as Chief Executive Officer and Andrew
Koven as President and Chief Business Officer to lead the strategic
effort. In anticipation of the approval and commercialization of
YOSPRALA, the potential for significant global business and commercial
activities and the expected financial benefits arising therefrom, the
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in